CN102727851A - Chinese herbal medicine used for treating cardiovascular and cerebrovascular diseases - Google Patents
Chinese herbal medicine used for treating cardiovascular and cerebrovascular diseases Download PDFInfo
- Publication number
- CN102727851A CN102727851A CN2012102231783A CN201210223178A CN102727851A CN 102727851 A CN102727851 A CN 102727851A CN 2012102231783 A CN2012102231783 A CN 2012102231783A CN 201210223178 A CN201210223178 A CN 201210223178A CN 102727851 A CN102727851 A CN 102727851A
- Authority
- CN
- China
- Prior art keywords
- grams
- medicine
- chinese herbal
- heart disease
- treating cardiovascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese herbal medicine used for treating cardiovascular and cerebrovascular diseases. The medicine is composed of an effective component and a pharmaceutically acceptable carrier. The effective component is prepared from the medicine materials of, by weight, 50g of prepared common monkshood daughter root, 18g of largehead atractylodes rhizome, 20g of white peony root, 30g of tuckahoe, 50g of spirit heart fruit, 15g of Mongolian snakegourd rind, 10g of longstamen onion bulb, 50g of medicinal plantain, 3g of raw pinellia, 10g of cassiabarktree twig, 20g of black snake, 6g of martin fig root and stem, 1g of blackend swallowwort root and rhizome, and 20g of ginger. The Chinese herbal medicine provided by the invention has a substantial effect in treating cardiovascular and cerebrovascular diseases.
Description
Technical field
The present invention relates to field of medicaments, is a kind of Chinese herbal medicine of treating cardiovascular and cerebrovascular disease specifically.
Background technology
Diseases such as myocarditis, rheumatic heart disease, coronary heart disease, cerebral thrombosis, cerebral infarction, pulmonary heart disease are very common; The patient person in middle and old age are more; This disease is that myocarditis is not controlled or obstinate causes rheumatic heart disease, coronary heart disease, cerebral thrombosis, cerebral infarction, pulmonary heart disease, and promptly heart disease has different names of disease according to the cause of disease and the state of an illness.Patient's this disease tangible medicine treatment that is of no curative effect at present.
Summary of the invention
In order to address the above problem, the invention provides a kind of herbal composite of treating cardiovascular and cerebrovascular disease.
The technical scheme of employing of the present invention is: a kind of Chinese herbal medicine of treating cardiovascular and cerebrovascular disease, to form by effective ingredient and pharmaceutically acceptable carrier, and described effective ingredient is processed by following bulk drugs by weight: Radix Aconiti Lateralis Preparata 50 grams, the Rhizoma Atractylodis Macrocephalae 18 grams; The Radix Paeoniae Alba 20 grams, Poria 30 grams, clever heart fruit 50 grams, melon shell 15 grams; Bulbus Allii Macrostemonis 10 grams, medicine Musa basjoo Sieb. Et Zucc. 50 grams are given birth to half time 3 gram, Ramulus Cinnamomi 10 grams; Zaocys 20 grams, Radix seu Caulis fici Martinii 6 grams, Radix Alangii 1 gram, Rhizoma Zingiberis Recens 20 grams.
Wherein, described effective ingredient is processed by following bulk drugs by weight: Radix Aconiti Lateralis Preparata 50 grams, the Rhizoma Atractylodis Macrocephalae 18 grams, the Radix Paeoniae Alba 20 grams; Poria 30 grams, clever heart fruit 50 grams, melon shell 15 grams, Bulbus Allii Macrostemonis 10 grams; Medicine Musa basjoo Sieb. Et Zucc. 50 grams are given birth to half time 3 gram, Ramulus Cinnamomi 10 grams, Zaocys 20 grams; Radix seu Caulis fici Martinii 6 grams, Radix Alangii 1 gram, Rhizoma Zingiberis Recens 20 grams.
The invention has the beneficial effects as follows: treatment heart disease, need only from dredging the meridian, rebuild one's physical constitution and start with, use the medicine of eliminating pathogenic factor for supporting vital QI, use the recuperating depleted YANG medicine, spleen meridian of Foot-TAI YIN.Annotate in the heart, vexatious, acute pain in the epigastrium.So the medicine of taking this medicine recuperating depleted YANG and rescuing the patient from collapse recovers the function of taste, just can cure because deficiency of heart-blood, heart disease that myocarditis caused.
In prescription of the present invention, Radix Aconiti Lateralis Preparata recuperating depleted YANG and rescuing the patient from collapse, warming and recuperating the spleen and kidney, dispersing cold for relieving pain.The big heat of Da Xin, warming YANG is by cold; Rhizoma Pinelliae stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass; Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI, dampness diuretic; Radix Paeoniae Alba easing the affected liver nourishes blood; Poria is calmed the nerves; Melon shell promoting the circulation of QI the chest stuffiness relieving; The Bulbus Allii Macrostemonis warming middle-JIAO activates yang, therapeutic method to keep the adverse QI flowing downwards eliminating stagnation; The Ramulus Cinnamomi warming the meridian and promoting blood circulation; The resolving phlegm and softening hard masses of medicine Musa basjoo Sieb. Et Zucc., suppressing the hyperactive liver, blood stasis dispelling is stimulated the menstrual flow; The Zaocys wind-damp dispelling, the meridian dredging; The Radix seu Caulis fici Martinii the meridian dredging; The Radix Alangii blood circulation promoting and blood stasis dispelling; Rhizoma Zingiberis Recens reduces phlegm, stomach function regulating; The spirit heart is really calmed the nerves, diabetes with polydipsia as the prominent symptom is scorching, blood stasis dispelling.It more than is the monarch medicine.To stop up through mediation; Activate atrophy, aged myocardial cell, reinforcing and reducing concurrently; Promoting circulation of QI-blood; Make the imbalance discord between the exterior and the interior, Ying Wei, negative and positive, internal organs, belong to harmonious purpose of coordinating to treat myocarditis, rheumatic heart disease, coronary heart disease, asthma, cerebral thrombosis, cerebral infarction, pulmonary heart disease disease again.
The specific embodiment
In order further to understand the present invention, below in conjunction with embodiment the preferred embodiment of the invention is described, describe just in order to further specify feature and advantage of the present invention but should be appreciated that these, rather than to the restriction of claim of the present invention.
Embodiment 1
A kind of Chinese herbal medicine of treating cardiovascular and cerebrovascular disease is made up of effective ingredient and pharmaceutically acceptable carrier, and described effective ingredient is processed by following bulk drugs by weight: Radix Aconiti Lateralis Preparata 50 grams, the Rhizoma Atractylodis Macrocephalae 18 grams; The Radix Paeoniae Alba 20 grams, Poria 30 grams, clever heart fruit 50 grams, melon shell 15 grams; Bulbus Allii Macrostemonis 10 grams, medicine Musa basjoo Sieb. Et Zucc. 50 grams are given birth to half time 3 gram, Ramulus Cinnamomi 10 grams; Zaocys 20 grams, Radix seu Caulis fici Martinii 6 grams, Radix Alangii 1 gram, Rhizoma Zingiberis Recens 20 grams.
Experimental example 1
This experimental example is intended to investigate through clinical trial the effect of the herbal composite of embodiment 1.
Referring to [new Chinese medicine treatment cardiovascular and cerebrovascular disease clinical research guideline].
Accept myocarditis 68 people for medical treatment, the medicine of oral embodiment 1, every day 3 times, each 5 grams (about 15), myocarditis course of treatment is 15 days.Effective percentage reaches 99%, and obvious effective rate reaches 99%.Inefficiency only accounts for 1%.Effectively: be that the finger-like myocarditis obviously reduces or eliminates.Produce effects: be that the finger-like myocarditis is eliminated fully or eliminated.Invalid: as to be meant that myocarditis does not obviously change or changes less than 1%.
Accept coronary heart disease 50 people for medical treatment, the medicine of oral embodiment 1, every day 3 times, each 5 grams (about 15), coronary heart disease course of treatment is 30 days.Effective percentage reaches 99%, and obvious effective rate reaches 98%.Inefficiency only accounts for 1%.
Accept rheumatic heart disease 125 people for medical treatment, the medicine of oral embodiment 1, every day 3 times, each 5 grams (about 15), rheumatic heart disease course of treatment is 30 days.Effective percentage reaches 98%, and obvious effective rate reaches 96%.Inefficiency only accounts for 2%.
Accept heart disease for medical treatment and cause apoplexy 80 people, the medicine of oral embodiment 1, every day 3 times, each 5 grams (about 15), apoplexy course of treatment is 30 days.Effective percentage reaches 88%, and obvious effective rate reaches 78%.Inefficiency only accounts for 2%.
The practical implementation therapeutic outcome is following:
Effective percentage reaches 87%, and obvious effective rate reaches 92%, and inefficiency only accounts for 12%, and this case amounts to 323 people.
Light disease case 68 people: be meant myocarditis, its treatment 15 days, 61 routine patient's symptoms are eliminated fully, and 7 examples were eliminated fully after 8 examples continued to take medicine 15 days, and 1 example alleviates.
Severe cases 255 people: be meant congenital heart disease, coronary heart disease, rheumatic heart disease. and with hypertension, diabetes, cerebral infarction, cerebral thrombosis, myocardial ischemia symptom; Average 30 days of its treatment time; Wherein 132 routine patients eliminate fully; 63 people eliminated fully after 123 examples continued to take medicine 30 days, and 53 people eliminated fully after 60 people continued to take medicine 30 days, and it is effective to remain 7 people.
Can find out that from above-mentioned clinical data the Chinese herbal medicine formula that the present invention adopted has significant effect for the treatment cardiovascular and cerebrovascular disease.
To the above-mentioned explanation of the disclosed embodiments, make this area professional and technical personnel can realize or use the present invention.Multiple modification to these embodiment will be conspicuous concerning those skilled in the art, and defined General Principle can realize under the situation that does not break away from the spirit or scope of the present invention in other embodiments among this paper.Therefore, the present invention will can not be restricted to these embodiment shown in this paper, but will meet and principle disclosed herein and features of novelty the wideest corresponding to scope.
Claims (2)
1. Chinese herbal medicine of treating cardiovascular and cerebrovascular disease is characterized in that:
Be made up of active ingredient and pharmaceutically acceptable carrying agent, described active ingredient is processed by following bulk drugs by weight: Radix Aconiti Lateralis Preparata 50 grams, the Rhizoma Atractylodis Macrocephalae 15 grams, the Radix Paeoniae Alba 20 grams; Poria 25 grams, clever heart fruit 50 grams, melon shell 15 grams, Bulbus Allii Macrostemonis 10 grams; Medicine Musa basjoo Sieb. Et Zucc. 50 grams are given birth to half time 10 gram, Ramulus Cinnamomi 10 grams, Zaocys 20 grams; Radix seu Caulis fici Martinii 6 grams, Radix Alangii 1 gram, Rhizoma Zingiberis Recens 20 grams.
2. treat congenital heart disease, coronary heart disease, rheumatic heart disease according to claim 1. and with the herbal composite of hypertension, diabetes, cerebral infarction, cerebral thrombosis, myocardial ischemia disease; It is characterized in that said herbal composite is processed tablet, capsule, granule, oral liquid or the watered pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102231783A CN102727851A (en) | 2012-07-02 | 2012-07-02 | Chinese herbal medicine used for treating cardiovascular and cerebrovascular diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012102231783A CN102727851A (en) | 2012-07-02 | 2012-07-02 | Chinese herbal medicine used for treating cardiovascular and cerebrovascular diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102727851A true CN102727851A (en) | 2012-10-17 |
Family
ID=46984616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012102231783A Pending CN102727851A (en) | 2012-07-02 | 2012-07-02 | Chinese herbal medicine used for treating cardiovascular and cerebrovascular diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102727851A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103690834A (en) * | 2013-12-30 | 2014-04-02 | 广西梧州制药（集团）股份有限公司 | Antihypertensive traditional Chinese medicinal composition and preparation method thereof |
-
2012
- 2012-07-02 CN CN2012102231783A patent/CN102727851A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103690834A (en) * | 2013-12-30 | 2014-04-02 | 广西梧州制药（集团）股份有限公司 | Antihypertensive traditional Chinese medicinal composition and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101537060B (en) | Medicine for treating AIDS | |
| CN103977358A (en) | Oral traditional Chinese medicine for lowering lipid and protecting liver | |
| CN101708237B (en) | Medicinal composition used for tonifying qi and invigorating pulse, preparation method thereof and application thereof | |
| CN103623280B (en) | A kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease | |
| CN101912567B (en) | Chinese medicinal prescription for treating chronic myocarditis | |
| CN102309549A (en) | Traditional Chinese medicine for preventing and treating hyperpyretic summer humidity disease | |
| CN105878454B (en) | Pharmaceutical composition for treating apoplexy hemiplegia and rheumatism arthralgia and preparation method thereof | |
| CN101954061B (en) | Medicine for treating chronic laryngitis | |
| CN102727851A (en) | Chinese herbal medicine used for treating cardiovascular and cerebrovascular diseases | |
| CN102935214B (en) | Traditional Chinese medicinal composition for treating uremia | |
| CN101647880A (en) | Medicament for treating appendicitis and preparation method thereof | |
| CN101623457B (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN101229360B (en) | Anti-AIDS medicine | |
| CN101327293A (en) | Capsules for treating peptic ulcer and preparation method thereof | |
| CN100382833C (en) | Mastosis treating Chinese medicine | |
| CN104127645A (en) | Traditional Chinese medicament with effects of removing slough and promoting growth of tissue regeneration and preparation method thereof | |
| CN103961658A (en) | Capsule preparation for lowering lipid and protecting liver | |
| CN101129571A (en) | Oral liquid of prunella spike | |
| CN103083613A (en) | Traditional Chinese medicine composition for treating migraine | |
| CN101607007B (en) | Traditional Chinese medicine preparation for treating cerebral circulation insufficiency | |
| CN101474389A (en) | Chinese medicine composition for treating cervical vertebra hyperosteogeny | |
| CN101979058B (en) | Chinese medicament for treating chronic nephritis | |
| CN101647965A (en) | Internal medicine for treating chronic nephritis | |
| CN101745071A (en) | Medicine for treating cholecystitis | |
| CN105106540A (en) | Medicinal preparation for treating cerebral thrombosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121017 |